GleamWall
中文EN

PRGO PERRIGO Co plc

Pharmaceutical Preparations · NYSE · SEC CIK 1585364 · Fiscal year ends 12/31

Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.5%
TTM net income YoY-3,316.4%
TTM EPS YoY-3,351.4%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—

Margins

Gross margin32.3%
Operating margin-39.4%
Net margin-43.3%
FCF margin4.1%
EBITDA margin-33.6%

Returns

ROE-51.4%
ROA-20.1%
ROIC (approx.)-19.7%
Asset turnover0.47x

Leverage & solvency

Liabilities / assets67.4%
Debt / equity1.35x
Current ratio2.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.14x
Accruals ratio-22.9%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-262026Q22026-06-272026Q12026-03-282025Q4*2025-12-312025Q32025-09-272025Q22025-06-282025Q12025-03-292024Q4*2024-12-31
Income statement
Revenue$988.60M$1.02B$969.20M$1.11B$1.04B$1.06B$1.04B$1.14B
Cost of revenue$667.80M$708.90M$643.70M$747.40M$666.20M$693.40M$651.60M$752.40M
Gross profit$320.80M$313.90M$325.50M$362.20M$377.10M$362.90M$392.30M$385.90M
R&D expense$21.90M$23.70M$24.60M$21.80M$24.90M$22.00M$26.70M$27.80M
SG&A expense$124.50M$100.00M$115.00M$116.50M$94.20M$113.00M$112.20M$94.70M
Operating income$23.10M$23.50M-$372.30M-$1.29B$72.60M$45.40M$46.90M$114.20M
Pretax income-$18.10M$105.40M-$408.50M-$1.33B$22.40M$3.20M$8.30M$70.00M
Income tax-$3.80M$16.90M-$18.70M$82.90M$9.70M$3.70M$8.20M$111.50M
Net income-$27.50M$74.50M-$398.60M-$1.42B$7.50M-$8.40M-$6.40M-$44.50M
EBITDA$50.60M$64.90M-$289.00M-$1.20B$102.00M$74.70M$126.80M$194.50M
EPS (basic)-0.200.54-2.87—0.05-0.06-0.05—
EPS (diluted)-0.200.53-2.87—0.05-0.06-0.05—
Dividends declared per share0.290.290.290.290.290.290.290.29
Weighted avg. shares (diluted)139.40M139.60M138.70M—138.90M138.20M137.70M—
Balance sheet
Cash & equivalents$436.60M$399.70M$357.20M$531.60M$432.10M$454.20M$409.90M$558.80M
Receivables$685.50M$709.90M$697.10M$612.80M$644.40M$678.20M$716.80M$642.30M
Inventory$1.01B$1.06B$1.12B$1.15B$1.23B$1.22B$1.16B$1.08B
Current assets$2.40B$2.45B$2.71B$2.80B$2.88B$2.62B$2.53B$2.48B
PP&E, net$825.10M$849.00M$877.70M$898.70M$902.80M$913.90M$913.20M$917.80M
Goodwill$1.69B$1.69B$1.70B$2.05B$3.36B$3.48B$3.38B$3.32B
Intangibles$4.55B$4.55B$4.58B$4.76B$4.74B$4.94B$4.66B$4.50B
Total assets$7.48B$7.61B$7.98B$8.54B$10.08B$10.09B$9.76B$9.65B
Current liabilities$1.02B$1.05B$997.60M$1.01B$1.15B$1.13B$1.07B$1.04B
Short-term debt$11.30M$11.40M$11.40M$36.60M$36.60M$36.40M$36.20M$36.40M
Long-term debt$3.28B$3.28B$3.62B$3.60B$3.61B$3.62B$3.59B$3.58B
Total debt$3.29B$3.29B$3.63B$3.64B$3.64B$3.65B$3.63B$3.62B
Total liabilities$5.04B$5.09B$5.48B$5.60B$5.64B$5.62B$5.40B$5.33B
Shareholders' equity$2.44B$2.52B$2.50B$2.94B$4.45B$4.47B$4.36B$4.32B
Net debt$2.86B$2.90B$3.28B$3.11B$3.21B$3.20B$3.22B$3.06B
Shares outstanding138.80M138.70M138.10M137.60M137.60M137.60M137.20M136.50M
Cash flow statement
Operating cash flow$96.20M$82.60M-$113.60M$175.40M$51.70M$75.90M-$64.50M$312.60M
Capital expenditure$17.50M$14.30M$13.80M$26.80M$21.90M$19.20M$25.50M$37.70M
Free cash flow$78.70M$68.30M-$127.40M$148.60M$29.80M$56.70M-$90.00M$274.90M
Investing cash flow-$13.60M$349.40M-$12.40M-$24.50M-$21.40M-$3.80M-$25.70M-$37.10M
Financing cash flow-$43.50M-$388.90M-$45.30M-$54.40M-$50.30M-$54.00M-$61.80M-$1.15B
Depreciation & amortization$27.50M$41.40M$83.30M$85.90M$29.40M$29.30M$79.90M$80.30M
Stock-based compensation$10.10M$6.80M$14.40M$13.00M$13.20M$16.80M$11.60M$19.90M
Dividends paid$40.20M$40.20M$39.90M$39.90M$39.90M$38.90M$40.60M$39.60M

Free plan shows the latest 8 periods; Pro shows all 60 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.